Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

Together Trial, Famotidine Arm, NCT04727424, TOGETHER, NCT04727424, Nov 2023

Famotidine for COVID-19

25th treatment shown to reduce risk in October 2021, now with p = 0.00072 from 29 studies, recognized in 2 countries.

No treatment is 100% effective.
Protocols combine treatments.

528 patient famotidine early treatment RCT with results not reported over 3 years after completion.
Together Trial et al., 1 Nov 2023, Double Blind Randomized Controlled Trial, placebo-controlled, trial NCT04727424 (history) (TOGETHER). Contact: administrador@cardresearch.org, duduaugusto1@yahoo.com.br.